RE: Markku has been quiet of late19 Aug 2022 00:42
Haematokine gets quite a bit of attention , again , with the potential for partnerships whilst still in trial and relatively quick entry into market ( compared to some )
Yet Traumakine gets no mention at all.
Bet cannot get traction , along with Traumakine , but hey , lets just flag up Team again to deflect attention.
And then we'll just grab a few more quid via a placing and dilute the small guys.
And no SSV to be seen.